The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
The release of monomers from the homotetrameric protein transthyretin (TTR) is the first event of a cascade, eventually leading to sporadic or familial TTR amyloidoses. Thus, ligands able to stabilize TTR and inhibit monomer release are subject of intense scrutiny as potential treatments against the...
Saved in:
Main Authors: | Francesco Bemporad (Author), Manuela Leri (Author), Matteo Ramazzotti (Author), Massimo Stefani (Author), Monica Bucciantini (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021) -
A review of transthyretin cardiac amyloidosis
by: Jhawar Nikita, et al.
Published: (2023) -
Combinatorial screening for therapeutics in ATTRv amyloidosis identifies naphthoquinone analogues as TTR-selective amyloid disruptors
by: Ryoko Sasaki, et al.
Published: (2023) -
Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study
by: Marco Fiore, et al.
Published: (2024) -
A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021)